期刊文献+

益髓生血颗粒治疗血红蛋白H病25例临床观察 被引量:11

Clinical observation of Yisui Shengxue Granule in treating 25 patients with hemoglobin H disease
下载PDF
导出
摘要 目的:研究益髓生血颗粒治疗血红蛋白H(hemoglobin H,HbH)病的临床效果及安全性。方法:观察益髓生血颗粒治疗前后25例HbH病患者血红蛋白(hemoglobin,Hb)浓度、红细胞(red bloodcell,RBC)计数、HbH含量及网织红细胞(reticulocyte,Ret)计数的动态变化及疗效;同时检测患者的基因类型,比较益髓生血颗粒治疗前后不同基因型患者血液参数的变化及疗效。结果:25例患者自服药第1个月起至疗程(3个月)结束,血液参数Hb、RBC、Ret水平均明显提高,与治疗前比较,差异有统计学意义(P<0.01)。经益髓生血颗粒治疗后,12例基因缺失型患者Hb、RBC、Ret明显提高(P<0.05,P<0.01),13例基因非缺失型患者Hb、Ret明显提高(P<0.05,P<0.01)。25例患者经3个月治疗后的总有效率为84%,中药对基因缺失型和非缺失型患者的疗效比较,差异无统计学意义。治疗期间患者未出现任何不良反应。结论:益髓生血颗粒治疗HbH病疗效显著,用药安全,可明显提高患者Hb、RBC、Ret水平,尤其以基因缺失型患者为佳。 Objective:To investigate the clinical efficacy and safety of Yisui Shengxue Granule(YSSXG),a compound traditional Chinese herbal medicine for reinforcing kidney and nourishing blood,in treating hemoglobin H(HbH)disease.Methods:YSSXG was given orally to 25 patients with HbH disease in Guangxi Zhuang Autonomous Region(high incidence area for HbH disease in China)for 3 months as one therapeutic course,3 times a day,10 g YSSXG was given each time(dose of YSSXG for children should be reduced properly),and blood transfusion was not given to HbH patients during the course of treatment.The levels of hemoglobin(Hb),red blood cell(RBC),HbH and reticulocyte(Ret)were observed before and after YSSXG treatment,and side effects were observed during the course of treatment.Meanwhile,the genotype was examined,and the clinical efficacy of YSSXG in treating HbH patients with different genotype was evaluated.Results:The levels of Hb,RBC and Ret were obviously increased after YSSXG treatment from the first month to the end of treatment(P〈0.01).After YSSXG treatment,the levels of Hb,RBC,Ret in 12 HbH patients with gene deletion were elevated(P〈0.05,P〈0.01),and the levels of Hb and Ret in 13 HbH patients with gene non-deletion were increased obviously(P〈0.05,P〈0.01).The total response rate was 84% after 3-month treatment,and there was no statistical difference in clinical efficacy between gene deletion HbH patients and non-deletion HbH patients.No adverse effect was observed during the course of treatment.Conclusion:YSSXG is effective and safe for treatment of HbH disease.YSSXG can improve the levels of Hb,RBC and Ret in HbH patients,especially in gene deletion HbH patients.
出处 《中西医结合学报》 CAS 2008年第2期153-156,共4页 Journal of Chinese Integrative Medicine
基金 国家自然科学基金重大研究计划(No.90409003) 国家自然科学基金(No.30171199)
关键词 补肾填精 益气生血 Α-地中海贫血 临床试验 reinforcing kidney and supplying emission reinforcing qi and nourishing blood alpha-thalassemia clinical trials
  • 相关文献

参考文献4

二级参考文献12

  • 1吴志奎,蔡辉国,陈佩贞,姜葆华,崔京华,王荣新,黄有文,纪新军,黄霞珍.补肾生血方对β—地中海贫血基因水平的影响[J].中医杂志,1997,38(2):91-93. 被引量:41
  • 2Higgs DR, Vickers MA, Wilkie AOM, et al. A review of the molecular genetics of the human α-globin gene cluster.Bood,1989,73:1081-1104.
  • 3Viprakasit V, Tanphaichitr VS, Pung-Amritt P, et al. Clinical phenotypes and molecular characterization of Hb H-Pakse disease. Haematologica,2002, 87: 117-125.
  • 4Chan V, Yam I, Chen FE, et al. A reverse dot-blot method for rapid detection of non-deletion alpha thalassaemia. Br J Haematol ,1999,104:513-515.
  • 5Kattamis C, Tzotzos S, Kanavakis E, et al. Correlation of clinical phenotype to genotype in haemoglobin H disease.Lancet,1988,1:442-444.
  • 6Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol, 2004 ,57:517-522.
  • 7Kanavakis E, Papassotiriou I, Karagiorga M, et al. Phenotypic and molecular diversity of haemoglobin H disease: a Greek experience.Br J Haematol,2000,111:915-923.
  • 8Forget BG. Thalassemia syndromes .In: Hoffman R, Benz EJ Jr, Shatti SJ, eds. Hematology: basic principle and practice.3rd ed. Singapore: Harcourt Asia PTE.LTD,2000.485-510.
  • 9Schrier SL, Bunyaratvej A, Khuhapinant A, et al. The unusual pathobiology of hemoglobin Constant Spring red blood cells.Blood,1997,89:1762-1769.
  • 10赵永忠,徐湘民,徐钤.PCR-LIS-SSCP快速分析非缺失型α-地中海贫血点突变[J].中华医学遗传学杂志,1999,16(2):113-115. 被引量:29

共引文献55

同被引文献101

引证文献11

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部